TEMPLE LEAVES Trademark

Trademark Overview


On Friday, February 16, 2024, a trademark application was filed for TEMPLE LEAVES with the United States Patent and Trademark Office. The USPTO has given the TEMPLE LEAVES trademark a serial number of 98409350. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 17, 2024. The TEMPLE LEAVES trademark is filed in the Pharmaceutical Products category with the following description:

Herbal drinks for medical purposes; liquid herbal supplements
temple leaves

General Information


Serial Number98409350
Word MarkTEMPLE LEAVES
Filing DateFriday, February 16, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHerbal drinks for medical purposes; liquid herbal supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 16, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressCollege Grove, TN 37046

Trademark Events


Event DateEvent Description
Saturday, February 17, 2024NEW APPLICATION ENTERED
Friday, June 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 5, 2024ASSIGNED TO EXAMINER
Tuesday, September 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2024NON-FINAL ACTION WRITTEN